To understand the changing spectrum of neonatal infectious disease, one must first be familiar with the history, the variety of organisms and the progression of change of neonatal infections over the years. As progressively more immature neonates are surviving, the spectrum of infectious disease has changed in response to current medical practice responsible for this success and to selective pressures on the microorganisms. The surviving very low birth weight infants are at a significant risk for contracting infections from this expanding repertoire of pathogens. Microorganisms once thought seemingly benign and nonpathogenic are now commonly accepted as pathogens and are among the most likely organisms to cause infections in this extremely vulnerable patient population. When considering the possible identity of infecting organisms and attempting to tailor specific therapies to decrease unwanted consequences, one must consider the level of maturity and the age of neonate, as well as the intensity of care necessary for a successful outcome. This brief review focuses primarily on the changing spectrum of bacterial and fungal infections and will not substantially address viral infections.
Historical perspectives
In the 1950s, when there were few surviving very low birth weight (VLBW) infants, our therapeutic armamentarium was limited for those who did survive and, as a result, neonatal infection was essentially a condition of the term infant. At that time the organisms most likely to cause infection were Staphylococcus aureus and Escherichia coli. As our ability to support the survival of smaller, less mature infants progressed, the variety of microorganisms with the potential to cause infection expanded to include more opportunistic infecting organisms and those that were not previously accepted as true potential pathogens, such as the coagulase-negative staphylococci (CONS). [1] [2] [3] From the 1960s through the 1990s, Streptococcus agalactiae, group B streptococcus (GBS), overtook S. aureus as the primary Gram-positive infecting organism. [4] [5] [6] [7] Over the course of the following years, the list of not uncommon pathogens has continued to grow and be influenced by current medical practices and the pressures applied on these microorganisms from the rampant use of antimicrobials, including many broad-spectrum drugs that have contributed to the selection for multidrug-resistant organisms in and out of the hospital settings. CONS are now the most prevalent infecting organism in the neonatal setting, owing this distinction to the late-onset infection rate in neonatal intensive care units. [8] [9] [10] Joining these organisms are E. coli, and multidrug-resistant Gram-negative organisms including Pseudomonas, Klebsiella and the fungi. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Although systemic infection of the term newborn indeed occurs, severe sepsis is now primarily a complication of preterm delivery.
Early versus late infections
Infections of newborns were classically divided into early-onset sepsis (EOS), occurring within the first 7 days of life, and late-onset sepsis (LOS), occurring within the neonatal period after the 7th day of life. Early-onset infections are associated with intrapartum exposure to the infecting organisms. This includes in utero or transplacental acquisition, as well as acquisition of these organisms during labor and delivery. Today, the majority of EOS, approaching 90%, will present within the first 24 h of life. 13 The route of transmission or type of exposure can influence the timing of presentation. The earliest in utero exposure can come as a result of a maternal subclinical infection at any time during the pregnancy. This is seen in classic TORCH infections that may persist through the neonatal period, in which the mother may be unaware that she had any significant infections. These in utero infections are beyond the scope of this discussion except to make the point that the timing of in utero infection affects the consequences and ultimate outcomes. Early in utero infections may result in spontaneous abortions, preterm delivery, stillbirths, intrauterine growth retardation, congenital malformations or overt symptomatology at birth consistent with a long-standing infection.
In utero or transplacental acquisition that occurs in the immediate peripartum period, as well as acquisition of organisms during labor and delivery, can also result in early-onset infections. This may occur with or without the rupture of fetal membranes (ROM). Early-onset infection with Listeria monocytogenes is associated with hematogenous or transplacental transmission with intact fetal membranes. Prolonged ROM increases the risk of infection by ascending organisms from the maternal vaginal flora, including GBS, enteric Gram-negative organisms, gonococci, Chlamydia and some viral pathogens. The risk of infection increases with increasing length of time between ROM and delivery. Many investigations have addressed this and clearly established an increased risk of EOS after 18 h of ROM. [14] [15] [16] Acquisition of EOS is also associated with a number of other well-described factors that, if present, would support the need to consider observation or evaluation of the newborn for infection. These include a maternal fever >38 1C, chorioamnionitis, prolonged or preterm ROM, poor prenatal care, poor maternal nutrition, a history of recurrent abortion, low birth weight, maternal substance abuse, difficulty in delivery, birth asphyxia and meconium staining. 17, 18 Knowledge of the risks and timing of exposure to GBS that would result in early-onset infection has allowed for recommendations for interventions that have resulted in the successful decrease of early-onset GBS disease. After the implementation of the American College of Obstetricians and Gynecologists and Centers for Disease Control and Prevention recommendations for maternal screening for colonization and intrapartum antibiotic prophylaxis during labor for women with known GBS colonization or other risk factors, the occurrence of early-onset GBS disease was dramatically decreased. [19] [20] [21] [22] [23] Late-onset disease has, however, not been similarly affected as it is associated with postpartum acquisition of GBS.
Infection that is acquired in the postpartum period is primarily through horizontal transmission from family members or caregivers or through environmental exposures. Infections can be acquired through breast-feeding (human immunodeficiency virus and CMV) or by direct contact with family members or health-care workers. These types of contacts and exposures are especially important in infants, primarily preterm, with prolonged hospital stays, where they are more likely to be exposed to multidrug-resistant hospital-associated organisms potentially from contact with caregivers or contaminated equipment.
Preterm infants are at an extremely increased risk for both early-and late-onset infections secondary to multiple contributing factors. New definitions have been applied to EOS and LOS in the VLBW infant (<1500 g). As defined by the NICHD Neonatal Network, 24 EOS is an infection that occurs up to 72 h of life and LOS beyond 72 h. Included among these are the degree of prematurity and the associated medical interventions necessary for appropriate care, as well as increased risk of exposure to pathogens associated with extended stays in the hospital. The greater the degree of an infant's prematurity, the more likely they are to undergo some invasive intervention during their routine care and the more likely they are to be exposed to the organisms associated with infections. Immunological deficits of newborn and especially preterm infants significantly contribute to the risk of becoming infected after exposure to an organism. Components of the neonatal immune system lack preexisting memory and have both qualitative and quantitative deficiencies. Dysfunction in the naïve neutrophil has also been implicated in contributing to the pathology and severity of neonatal sepsis. [25] [26] [27] [28] Although term infants can mount adult-like immune responses, [29] [30] [31] [32] these occur under specific sets of circumstances and cannot be relied upon to be protective. Adding to the risk of infection in the preterm infant is the fact that they have failed to acquire protective maternal antibodies that would have been transferred during the late third trimester of pregnancy.
Impact of gestational age on infection: term versus preterm infections
The changing spectrum of neonatal infectious disease is infection of the VLBW infant with opportunistic and aggressive multidrugresistant pathogens. VLBW infants accounted for 1.48% of all deliveries in 2006 for a total of 63 136 births. 33 Approximately one-third of these infants weighed <1000 g. The risk of infections for this population is significant. Where only an estimated 0.1% of term infants will have an infection in the neonatal period, 20% of VLBW infants will be infected during their hospital stay. 24, 34, 35 The incidence of sepsis increases with decreasing gestational age. Stratified by weight, 10% of 1000 to 1500 g infants, 35% of <1000 g infants and 50% of <750 g infants will have the diagnosis of sepsis during the neonatal period. Most bouts of sepsis in this population will occur after the third day of life. The NICHD Neonatal Research Network survey from 1998 to 2000 and the Vermont Oxford Network 2001 database summary reported similar rates (of 1.5 and 2%, respectively), of VLBW infants with EOS, and both reported 21% for VLBW infants with LOS. The NICHD also reported that 46% of infants born at <25 weeks gestation had LOS. 24 Although most VLBW infants who have sepsis will have only a single infection, 28% will have more than one, 20% will have two, 6% will have three and 2% will have more than three. Multiple episodes of sepsis increase with lower birth weights, and 40% of infants weighing <750 g will have two or more episodes of sepsis. 24 Most strikingly, sepsis is responsible for B50% of neonatal deaths after 2 weeks of life 10 and VLBW infants who have sepsis have a mortality rate that approaches three times that of those without sepsis. 24 Routes of infection There are many avenues through which a newborn might become infected. Initially, during a vaginal delivery the infant is exposed to all the organisms in the birth canal and the physical barrier of intact skin protects them from infection. At this time the infant may become colonized or, if the skin is not intact owing to external monitors, abrasions or injury suffered during the delivery, infected. Other potential routes of infection include the umbilical cord, conjunctiva, oropharynx, gastrointestinal and respiratory tracts. Infants who require extended hospital stays and advanced support with indwelling foreign bodies such as persistent intravenous lines, endotracheal tubes, urinary catheters and shunts are at increased risk. Even respiratory support with something as seemingly benign as a nasal cannula can increase the risk if surrounding tissues are allowed to become eroded due to contact with foreign material. Additional contributing factors to late-onset infection in VLBW infants are the repeated courses of broad-spectrum antibiotics that initially delay the establishment of probiotic normal flora and select for drug-resistant organisms and fungal infection in individual hosts. Repeated blood draws and other invasive procedures may also contribute to the high LOS rates, especially in VLBW infants, in whom routine blood draws may be difficult, requiring multiple attempts.
Types of infections
Although dominating this discussion, neonatal infections are not limited to severe systemic infections such as sepsis. VLBW neonates also succumb to a variety of focal infections, some associated with sepsis, including pneumonia, meningitis, urinary tract infections (UTIs) and superficial skin infections. These infections can be caused by the same bacterial and fungal agents that are responsible for causing sepsis and likewise may be challenging to diagnose, and are briefly discussed here. Pneumonia in the endotracheally intubated VLBW infant may be the most difficult focal infection to diagnose. Radiographic findings and clinical presentation in pneumonia may be indistinguishable from bronchopulmonary dysplasia or chronic lung disease. [36] [37] [38] Distinguishing colonization from infection based on white blood cell counts, Gram stains and cultures obtained from endotracheal tube aspirates is unreliable.
Meningitis in the VLBW infant, defined as a positive cerebral spinal fluid (CSF) culture, has been and remains a difficult diagnosis to make. [39] [40] [41] [42] Many factors contribute to the underdiagnoses and potential inadequate treatment of this condition. Often, attempts at CSF collection for microorganism isolation are delayed due to the patient's clinical status and antimicrobial therapies are initiated in the interim further decreasing the chance of isolating viable bacteria. In recent studies, investigators have confirmed that meningitis in the VLBW infant can occur without associated bacteremia or abnormalities in CSF. 39 They further showed that CSF parameters, used to support or exclude the diagnosis in older children, and peripheral white blood cell counts were not helpful in making the diagnosis in VLBW infants and that a positive CSF culture was critical.
Although it is generally accepted that infection may be a predisposing factor as well as a result of necrotizing enterocolitis, it is clear that its etiology extends beyond simple infection and as such an extensive discussion is beyond this review. UTIs are diagnosed when organisms are present in appropriately collected urine samples. The overall incidence of UTI in VLBW is reported at 8.1%, stratified as 5.7% for infants weighing 1000 to 1500 g and increasing to 12.5% for those <1000 g. 43 Depending on the organism, at least 100 colony-forming units (CFU) ml -1 from a suprapubic bladder aspiration or 10 000 CFU ml -1 from a sterile bladder catheterization is required for diagnosis, or less for Gram-negative organisms or fungi. 43, 44 Evaluation for a UTI is not indicated for VLBW infants in the first 72 h of life. 45 However, beyond this period, when urine is no longer considered sterile, it should be included in the evaluation of a symptomatic infant.
Organisms associated with EOS and LOS in VLBW infants
Timing of the onset of infection in the VLBW infant can also suggest the etiological agent and the associated morbidity and mortality. However, the clinical presentation is not unique to the individual organisms and therefore may not be helpful in determining the causative agent. The primary organisms responsible for EOS in VLBW may vary at different centers and over time, but remain primarily E. coli, GBS and CONS. 8, 46, 47 Data compiled from these and additional studies 34, [47] [48] [49] and reviewed 8 show that in sepsis that presents in <72 h, about 61% were caused by Gram-negative organisms, with an associated mortality of 41, and 37% were caused by Gram-positive organisms, with an associated mortality of 26%. Fungal infections with Candida albicans accounted for only 2.4% of EOS. Of the Gram-negative organisms causing EOS, 44% were E. coli, over 8% were Haemophilus influenza and Citrobacter, and Bacteroides and Klebsiella accounted for B6% of the infections. Of the Gram-positive organisms causing EOS, GBS and CONS each were responsible for 9% of infections, followed by Viridans streptococci and other streptococci (8.4%), L. monocytogenes (2.4%) and S. aureus (1.2%).
Sepsis that occurred after 72 h of life was primarily caused by Gram-positive bacteria 24, 49, 50 with an overall mortality of 11.2%. Of these, the majority of events were caused by CONS, with the lowest mortality (9.1%) associated with any infecting organism. However, when sepsis was caused by GBS, there was an associated 21.9% mortality. The other Gram-positive organisms causing LOS were S. aureus (7.8%), with 17.2% mortality, and Enterococcus species (3.3%). Only 17.6% of LOS was associated with Gram-negative organisms, but with a reported 36% mortality. The greatest risk for death was associated with Pseudomonas sepsis, with 2.7% of the infections but 74% mortality. Other LOS-associated Gram-negative organisms were E. coli, representing 4.9% of infections with 34% mortality; Klebsiella, 4% of infections with 22.6% mortality; Enterobacter, 2.5% of infections with 26.8% mortality; and Serratia, 2.2% of infections with 35.9% mortality. Lastly, fungal infections accounted for 12.2% of the LOS with 31.8% mortality. C. albicans accounted for 5.8% of LOS infections with 43.9% mortality and C. parapsilosis accounted for 4.1% of infections with 15.9% mortality.
Diagnosis and treatment
Diagnosis of neonatal infections is challenging. Most infants will have some risk factors and the presenting symptoms are many and nonspecific, including poor feeding, breathing difficulty, apneas and bradycardia, gastrointestinal problems, increased oxygen requirement or ventilator support needs, lethargy or hypotension, decreased or elevated temperature, unusual skin rash or color change, persistent crying or irritability. Adding to the challenge of correctly identifying the infection, the list of conditions to consider in the differential diagnosis is extensive, including metabolic and congenital abnormalities. As a result, the most common presenting symptoms have low positive predictive value (PPV) for culture-proven sepsis, only 14 to 20%, and the symptom with the highest PPV, hypotension (PPV 31%), is present only in 5% of culture-proven events. 50 Although isolation of a microorganism from the blood is the standard for diagnosis of sepsis, this is challenging as well. Only one in five evaluations for sepsis will produce a positive blood culture. Therefore, when considering a possible diagnosis, the chances of getting a false-negative culture from an infant with significant risk factors and strong clinical indicators support the diagnosis of clinical sepsis. In one report of autopsy data of ELBW infants, 61% of infections diagnosed at necropsy were not diagnosed before death. 51 Other complicating factors include maternal antimicrobial therapy before birth as well as the low blood volume often collected for these cultures. 52 In one recent study there was a 60% false-negative culture rate if <4 CFU of bacteria were present per ml and if <0.5 ml of blood was collected. Altogether, empirical therapy is given 80% of the time, with no identified microorganism. 24 Another recent study investigating the value of single versus multiple blood cultures for the diagnosis of sepsis showed that two-site blood cultures were not better than a single culture if X1 ml of blood was collected. 53 Standard laboratory evaluations for white blood cell counts with differential determination and platelet counts as well as adjunctive tests may be helpful to support the diagnosis of sepsis and useful to follow the progression, but are not diagnostic.
Conclusions
Despite significant advances in health care, infection in the neonate, especially in the preterm VLBW newborn, remains an extremely important cause of morbidity and mortality. Adequate diagnosis in this unique population can be extremely challenging. Successful treatment relies on early recognition, diagnosis and appropriate targeted supportive and antimicrobial therapies. As the total number of births of VLBW infants remains high, the challenges are now to develop strategies and practices to prevent neonatal infections; to develop novel specific therapies to eradicate infecting organisms without selecting for worse pathogens; and to develop better diagnostic tools.
